Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said 5 Sep 2025 · doblin-0269
Quote
Not a forecast
“MAPS is now engaged in discussions with people in the administration, not in the FDA, about whether we already have an evidence-based therapy.”
Doblin describes a route to approval that avoids a further Phase 3 trial.
Descriptive, retrospective, or a statement of preference; no future state asserted.